HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-13
DOI
10.1007/s12031-020-01505-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medulloblastoma
- (2019) Paul A. Northcott et al. Nature Reviews Disease Primers
- Childhood cerebellar tumours mirror conserved fetal transcriptional programs
- (2019) Maria C. Vladoiu et al. NATURE
- A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma
- (2019) Ekaterina Pak et al. NEURO-ONCOLOGY
- Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
- (2019) Ae Kyung Park et al. BMC CANCER
- Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma Tumorigenesis
- (2019) Miller Huang et al. Cell Stem Cell
- Biological characterization of the UW402, UW473, ONS-76 and DAOY pediatric medulloblastoma cell lines
- (2019) Ricardo Bonfim-Silva et al. CYTOTECHNOLOGY
- pathfindR: An R Package for Comprehensive Identification of Enriched Pathways in Omics Data Through Active Subnetworks
- (2019) Ege Ulgen et al. Frontiers in Genetics
- Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma
- (2019) M. Hope Robinson et al. Scientific Reports
- Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma
- (2018) Bárbara Kunzler Souza et al. MOLECULAR NEUROBIOLOGY
- Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
- (2017) Edward C Schwalbe et al. LANCET ONCOLOGY
- The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival
- (2017) Eric M Thompson et al. NEURO-ONCOLOGY
- Cancer stem cells: The root of tumor recurrence and metastases
- (2017) Claudia Peitzsch et al. SEMINARS IN CANCER BIOLOGY
- Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells
- (2017) Juan Yuan et al. CELLULAR ONCOLOGY
- Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model
- (2017) Ji Hoon Phi et al. Oncotarget
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- In vitro models of medulloblastoma: Choosing the right tool for the job
- (2016) Delyan P. Ivanov et al. JOURNAL OF BIOTECHNOLOGY
- Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
- (2016) Carmela Ciccarelli et al. Molecular Cancer
- Isolation and characterization of cancer stem cells from medulloblastoma
- (2015) J. Liu et al. GENETICS AND MOLECULAR RESEARCH
- Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
- (2015) Jonas Ecker et al. Acta Neuropathologica Communications
- Epigenetic States of Cells of Origin and Tumor Evolution Drive Tumor-Initiating Cell Phenotype and Tumor Heterogeneity
- (2014) Kin-Hoe Chow et al. CANCER RESEARCH
- Evolution of the Cancer Stem Cell Model
- (2014) Antonija Kreso et al. Cell Stem Cell
- The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
- (2014) Robert Huether et al. Nature Communications
- Selective HDAC1/HDAC2 Inhibitors Induce Neuroblastoma Differentiation
- (2013) Stacey M. Frumm et al. CHEMISTRY & BIOLOGY
- Brain tumor stem cells: Molecular characteristics and their impact on therapy
- (2013) David L. Schonberg et al. MOLECULAR ASPECTS OF MEDICINE
- The Histone Deacetylase Inhibitor Sodium Butyrate Promotes Cell Death and Differentiation and Reduces Neurosphere Formation in Human Medulloblastoma Cells
- (2013) Carolina Nör et al. MOLECULAR NEUROBIOLOGY
- Medullospheres from DAOY, UW228 and ONS-76 Cells: Increased Stem Cell Population and Proteomic Modifications
- (2013) Cristina Zanini et al. PLoS One
- FoxG1 Interacts with Bmi1 to Regulate Self-Renewal and Tumorigenicity of Medulloblastoma Stem Cells
- (2013) Branavan Manoranjan et al. STEM CELLS
- Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells
- (2012) Charn-Jung Chang et al. CHILDS NERVOUS SYSTEM
- The role of stem cells and progenitors in the genesis of medulloblastoma
- (2012) Jun Wang et al. EXPERIMENTAL NEUROLOGY
- Novel mutations target distinct subgroups of medulloblastoma
- (2012) Giles Robinson et al. NATURE
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models
- (2011) Ana-Maria Marino et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High levels of PROM1 (CD133) transcript are a potential predictor of poor prognosis in medulloblastoma
- (2011) A. Raso et al. NEURO-ONCOLOGY
- Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells
- (2011) X Wang et al. ONCOGENE
- Using a Stem Cell-Based Signature to Guide Therapeutic Selection in Cancer
- (2010) I. Shats et al. CANCER RESEARCH
- Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma
- (2010) Magdalena Zakrzewska et al. CHILDS NERVOUS SYSTEM
- Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity
- (2010) Cheng-Chia Yu et al. CHILDS NERVOUS SYSTEM
- Celecoxib enhances radiosensitivity in medulloblastoma-derived CD133-positive cells
- (2010) Kuan-Hsuan Chen et al. CHILDS NERVOUS SYSTEM
- Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks
- (2010) Kouichi Tabu et al. Molecular Cancer
- Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
- (2010) Jun Sunayama et al. STEM CELLS
- Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib
- (2009) Kei-ichi Ozaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evaluation of radiotherapy effect in resveratrol-treated medulloblastoma cancer stem-like cells
- (2009) Kai-Hsi Lu et al. CHILDS NERVOUS SYSTEM
- PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo
- (2008) D. Hambardzumyan et al. GENES & DEVELOPMENT
- Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype
- (2008) B. Annabi et al. MOLECULAR CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now